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Dinuclear metallohydrolases catalyze the degradation of many 
of the ubiquitous biomolecules in living organisms such as nucleic 
acids, phospholipids, and polypeptides.1-4 They are therefore key 
players in carcinogenesis, tissue repair, and protein degradation 
processes. Several of these enzymes have been crystallographically 
characterized, but despite their ubiquity and the wealth of structural 
information available little is known about how these structural motifs 
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relate to function. The importance of understanding the mechanism of 
action of dinuclear hydrolases is underscored by the recent 
observation that a eukaryotic dinuclear metallo-aminopeptidase is the 
target for the antitumor drugs ovalicin and fumagillin.5,6 In addition, 
the naturally occurring peptide analogue inhibitor, bestatin, was 
recently shown to significantly decrease HIV infection by inhibiting 
leucine aminopeptidase activity.7 In an effort to gain insight into the 
structure of the tetrahedral transition state of peptide hydrolysis, we 
have explored the nature of the interaction of l-leucinephosphonic acid 
(LPA) with the aminopeptidase from Aeromonas proteolytica (AAP).  
 
AAP is a small, monomeric enzyme (32 kDa) that is 
thermostable for several hours at 70 °C.8 AAP has been 
crystallographically characterized and contains a (μ-aqua)(μ-
carboxylato)dizinc(II) core with a terminal carboxylate and histidine 
residue coordinated to each metal ion.9 Bennett and Holz recently 
demonstrated that metal binding to AAP occurs in a sequential fashion, 
highlighting the potential for the formation of heterodimetallic 
sites.10,11 The addition of LPA to [CoZn(AAP)], monitored by electronic 
absorption spectroscopy, results in an increase in molar absorbtivity 
from 58 to 68 M-1 cm-1 with no shift in the λmax value of 525 nm 
(Figure 1A). On the other hand, the addition of LPA to [ZnCo(AAP)] 
(Figure 1B) results in a clear shift in λmax from 525 to 500 nm with a 
concomitant increase in the molar absorptivity to 63 M-1 cm-1. The 
visible absorption spectra of [CoZn(AAP)]-LPA and [ZnCo(AAP)]-LPA 
are comparable to the cobalt-substituted angiotensin converting 
enzyme (525 nm, ε ∼ 75 M-1 cm-1) and the noncatalytic site of native 
carboxypeptidase A (525 nm, ε ∼ 65 M-1 cm-1), both of which are 
proposed to be five coordinate.12,13 However, the absorption spectrum 
of [ZnCo(AAP)]-LPA exhibits fine structure comprised of five 
absorption bands at 488, 517, 549, 579, and 601 nm. Electronic 
absorption fine structure similar to that observed for [ZnCo(AAP)]-LPA 
is sometimes observed in severely distorted octahedral Co(II) 
species.14 Therefore, extensive distortions away from octahedral 
symmetry are likely responsible for the effects of LPA binding on the 
electronic absorption spectrum of [ZnCo(AAP)]. Taken together, these 
data suggest an interaction between LPA and each metal ion in the 
dinuclear catalytic center of AAP.  
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Figure 1 Electronic absorption spectrum of (A) a 1 mM buffered (50 mM Hepes; pH 
7.5; 20% 2-propanol) solution of [CoZn(AAP)] in the absence (dashed line) and 
presence (solid line) of 5 equiv of LPA, and (B) a 1 mM buffered (50 mM Hepes; pH 
7.5; 20% 2-propanol) solution of [CoZn(AAP)] in the absence (dashed line) and 
presence (solid line) of 5 equiv of LPA. Electronic absorption spectra were recorded on 
a Shimadzu UV-3101PC spectrophotometer. 
The EPR spectrum of resting [CoCo(AAP)] is shown in Figure 2A. 
The addition of LPA to [CoCo(AAP)] completely abolished the 
perpendicular mode EPR signal (Figure 2B). Examination of 
[CoCo(AAP)]-LPA in the parallel mode revealed an intense integer spin 
signal with a crossover point at g ∼ 10.3 at 9 K suggesting that the 
two S = 3/2 Co(II) ions are ferromagnetically coupled upon LPA 
binding. The signal exhibited maximum intensity at 4 K suggesting 
that it is a ground-state transition. Based on the reported magnetic 
properties of several μ-aquo and μ-hydroxo dicobalt(II) model 
complexes, weak to moderately strong antiferromagnetic coupling 
would be expected if LPA provided a single oxygen atom bridge.15,17 
Moreover, bis(μ-carboxylato)- and tetrakis(μ-carboxylato)dicobalt(II) 
cores show weak antiferromagnetic spin coupling.18-20 These data 
suggest that a single oxygen atom bridge is not present in the 
[CoCo(AAP)]-LPA complex and that the ferromagnetic coupling is not 
likely mediated through the carboxylate bridge. Interestingly, when 
bestatin, which provides a single alkoxide bridging atom, is added to a 
sample of [CoCo(AAP)] no parallel or perpendicular mode EPR signals 
are observed suggesting that the two high-spin Co(II) ions are 
antiferromagnetically coupled.21 Bestatin likely binds to AAP in a 
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fashion similar to d-iodophenylalanine hydroxamate which has been 
shown by X-ray crystallography to provide a single oxygen atom 
bridge between the two Zn(II) ions.22 Taken together, these data 
suggest that LPA and bestatin bind in different modes to the dinuclear 
Co(II) active site cluster of AAP.  
 
 
Figure 2 EPR spectra of a 1 mM buffered solution of [CoCo(AAP)]:  (A) perpendicular 
mode in the absence of LPA; (B) perpendicular mode in the presence of 5 equiv of 
LPA; and (C) parallel mode in the presence of 5 equiv of LPA. All samples were 
buffered with 50 mM Hepes, pH 7.5, containing 20% 2-propanol to prevent 
aggregation. All EPR spectra were recorded with a 1.26 mT modulation amplitude and 
a sweep rate of 10 mT s-1. Perpendicular mode spectra were recorded at 10 K, 0.2 mW 
microwave power while parallel mode spectra were recorded at 3.9 K, 2 mW 
microwave power. All EPR spectra were recorded on a Bruker ESP-300E spectrometer 
equipped with an ER 4116 DM dual-mode cavity and an Oxford Instruments ESR-900 
helium flow cryostat. 
EPR studies of [CoZn(AAP)] and [ZnCo(AAP)] revealed that the 
two EPR signals observed in the resting enzymes, which arise from a 
pH-dependent mixture of species,11 are replaced by signals due to a 
single species. For both [CoZn(AAP)]-LPA and [ZnCo(AAP)]-LPA a 
rhombic, 59Co hyperfine split species is observed that could be 
simulated as a single species (Figure 3).15 These data indicate that the 
environments of the Co(II) ions in both [CoZn(AAP)] and [ZnCo(AAP)] 
become highly asymmetric and constrained upon the addition of LPA 
and clearly indicate interaction of LPA with both metal ions. 
Interestingly, the 59Co hyperfine splitting for [ZnCo(AAP)]-LPA is 
significantly smaller than that observed for other Co(II)-substituted 
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AAP species and suggests delocalization of some 30% of the 
paramagnetic electron density from the cobalt nucleus. This implies a 
direct interaction of the Co(II) ion with an electrophilic moiety such as 
the N-terminal amine group of LPA which is also consistent with the 
anisotropy of greal for this species.  
 
 
Figure 3 EPR spectra of (A) [CoZn(AAP)] in 50 mM Hepes buffer, pH 7.5, containing 
20% 2-propanol; (B) [CoZn(AAP)] after the addition of 5 equiv of LPA; (C) simulation 
of (B) with geff = 1.90, 3.05, 6.66, Az(59Co) = 7.0 mT, Ms = |±1/2〉, greal = 2.53, E/D 
= 0.26; (D) [ZnCo(AAP)] in 50 mM Hepes buffer, pH 7.5, containing 20% 2-propanol; 
(E) [ZnCo(AAP)] in the presence of 5 equiv of LPA; and (F) simulation of (E) with geff = 
1.95, 3.40, 1.95, Az(59Co) = 4.95 mT, Ms = |±1/2〉, greal(x,y )= 2.204 and greal(z )= 
2.48, E/D = 0.2. All spectra were recorded at 10 K, 0.2 mW, 1.26 mT modulation 
amplitude and 10 mT s-1 sweep rate. All EPR simulations were performed with the 
programs EPRSim XOP and Rhombogram as previously described.10 
Combination of the optical and EPR data presented herein with 
the previously reported X-ray crystal structure of AAP9 provides 
structural information on the transition state of peptide hydrolysis as 
well as insight into the catalytic mechanism of AAP. Since LPA interacts 
with both metal centers and a single oxygen atom bridge is likely 
absent, LPA appears to bind to the dicobalt(II) cluster of AAP as an η-
1,2-μ-phosphonate with one ligand to the second Co(II) ion provided 
by the N-terminal amine. The proposed structure for LPA binding to 
AAP is consistent with preliminary X-ray crystallographic data for 
[ZnZn(AAP)] bound by LPA.21 On the basis of previously reported 
kinetic, thermodynamic, spectroscopic, and X-ray crystallographic data 
a detailed mechanism of action for AAP has recently been proposed.8,10 
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In this mechanism, the bridging water/(OH-) becomes terminal upon 
substrate binding and is bound to the first Zn(II) binding site 
consistent with the fact that (i) AAP is ca. 80% active with only a 
single Zn(II) ion bound, (ii) the substrate-analogue inhibitor 1-
butaneboronic acid interacts only with the first metal binding site, and 
(iii) fluoride binding occurs after substrate binding.8,23 At this point in 
the mechanism, the terminal metal bound hydroxide attacks the 
activated scissile carbonyl carbon of the peptide substrate forming a 
gem-diolate transition state complex with no single oxygen atom 
bridge. In addition, N-terminal amine binding to Zn2 suggests that 
electron density donation by the second metal ion is important in 
stabilizing the transition state. Amine binding to the second Mn(II) ion 
in arginase has been proposed to drive the loss of the bridging 
water/(OH-) to form a terminal hydroxide that functions as the 
nucleophile in the hydrolytic reaction.24 On the basis of these data we 
propose that N-terminal amine binding, in conjunction with hydrogen-
bond formation, likely functions to displace the bridging water/(OH-) 
thus placing it on Zn1 along with the substrate. Therefore, both metal 
ions are required for full enzymatic activity, but their individual roles 
appear to differ markedly.  
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